The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.
of the drug found that it delivered pain relief to some migraine sufferers in as little as 15 minutes.
The treatment for a condition generally tackled with orally taken medicines was double-blind tested on a sample of 1,405 people, with half taking a single spray dose and the remainder receiving a placebo.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Leer más »
Pfizer's fast-acting migraine nasal spray approved by FDAThe nasal spray is designed for quick relief of migraine headaches for those who can't take pills or injections.
Leer más »
New nasal spray approved to treat migraines in adults, Pfizer saysPfizer said the Food and Drug Administration has approved its new nasal spray for adults with migraines.
Leer más »
New nasal spray approved to treat migraines in adults, Pfizer saysPfizer said the Food and Drug Administration has approved its new nasal spray for adults with migraines.
Leer más »
Migraine nasal spray from Pfizer snags FDA approval for expected summer launchThe FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.
Leer más »
FDA approves nasal spray to treat migrainesZavzpret is the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute to migraines.
Leer más »